Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/207671
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBhandari, Vinayak-
dc.contributor.authorLi, Constance H.-
dc.contributor.authorBristow, Robert G.-
dc.contributor.authorBoutros, Paul C.-
dc.contributor.authorPCAWG Consortium-
dc.contributor.authorDeu-Pons, Jordi-
dc.contributor.authorFrigola, Joan-
dc.contributor.authorGonzález-Pérez, Abel-
dc.contributor.authorMuiños, Ferran-
dc.contributor.authorMularoni, Loris-
dc.contributor.authorPich, Oriol-
dc.contributor.authorReyes-Salazar, Iker-
dc.contributor.authorRubio-Perez, Carlota-
dc.contributor.authorSabarinathan, Radhakrishnan-
dc.contributor.authorTamborero, David-
dc.contributor.authorAymerich Gregorio, Marta-
dc.contributor.authorGelpi Buchaca, Josep Lluís-
dc.contributor.authorLópez Guillermo, Armando-
dc.contributor.authorRabionet Janssen, Raquel-
dc.contributor.authorCampo Güerri, Elias-
dc.date.accessioned2024-02-16T15:27:06Z-
dc.date.available2024-02-16T15:27:06Z-
dc.date.issued2020-02-05-
dc.identifier.issn2041-1723-
dc.identifier.urihttps://hdl.handle.net/2445/207671-
dc.description.abstractMany primary tumours have low levels of molecular oxygen (hypoxia), and hypoxic tumours respond poorly to therapy. Pan-cancer molecular hallmarks of tumour hypoxia remain poorly understood, with limited comprehension of its associations with specific mutational processes, non-coding driver genes and evolutionary features. Here, as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing data from 2658 cancers across 38 tumour types, we quantify hypoxia in 1188 tumours spanning 27 cancer types. Elevated hypoxia associates with increased mutational load across cancer types, irrespective of underlying mutational class. The proportion of mutations attributed to several mutational signatures of unknown aetiology directly associates with the level of hypoxia, suggesting underlying mutational processes for these signatures. At the gene level, driver mutations in TP53, MYC and PTEN are enriched in hypoxic tumours, and mutations in PTEN interact with hypoxia to direct tumour evolutionary trajectories. Overall, hypoxia plays a critical role in shaping the genomic and evolutionary landscapes of cancer.-
dc.format.extent10 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherNature Publishing Group-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/https://doi.org/10.1038/s41467-019-14052-x-
dc.relation.ispartofNature Communications, 2020, vol. 11, num.1, p. 1-10-
dc.relation.urihttps://doi.org/https://doi.org/10.1038/s41467-019-14052-x-
dc.rightscc-by (c) Bhandari, V. et al., 2020-
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/-
dc.sourceArticles publicats en revistes (Fonaments Clínics)-
dc.subject.classificationCàncer-
dc.subject.classificationGenòmica-
dc.subject.otherCancer-
dc.subject.otherGenomics-
dc.titleDivergent mutational processes distinguish hypoxic and normoxic tumours-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec728366-
dc.date.updated2024-02-16T15:27:06Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Fonaments Clínics)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Institut de Recerca Biomèdica (IRB Barcelona))

Files in This Item:
File Description SizeFormat 
255386.pdf1.73 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons